Scientists have developed an experimental blood test that may revolutionize dementia diagnosis by identifying multiple neurodegenerative diseases simultaneously. The test measures 15 proteins in the blood and can detect conditions such as Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, and dementia with Lewy bodies.
In a recent study, the test achieved an impressive 92.3% accuracy in determining whether a person had one or more of these conditions. Unlike current blood tests that focus mainly on Alzheimer’s, this approach provides a broader picture of brain health and disease overlap.
Researchers believe the technology could enable earlier, more precise diagnoses and help doctors tailor treatments to each patient’s unique condition, potentially improving outcomes and quality of life.
Read more at ScienceNews